These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33367524)

  • 1. Stability Indicating Method for Polysorbate 80 in Protein Formulations.
    Webster GK; Chang JC; Heflin JL
    J Chromatogr Sci; 2021 Aug; 59(8):706-713. PubMed ID: 33367524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of ferric thiocyanate derivatization for quantification of polysorbate 80 in high concentration protein formulations.
    Savjani N; Babcock E; Khor HK; Raghani A
    Talanta; 2014 Dec; 130():542-6. PubMed ID: 25159444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of polysorbate 80 in parenteral formulations by high-performance liquid chromatography and evaporative light scattering detection.
    Nair LM; Stephens NV; Vincent S; Raghavan N; Sand PJ
    J Chromatogr A; 2003 Sep; 1012(1):81-6. PubMed ID: 14509344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a selective marker-based quantification of polysorbate 20 in biopharmaceutical formulations using UPLC QDa detection.
    Evers DH; Schultz-Fademrecht T; Garidel P; Buske J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Nov; 1157():122287. PubMed ID: 33069954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways.
    Kerwin BA
    J Pharm Sci; 2008 Aug; 97(8):2924-35. PubMed ID: 17973307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous quantification of polysorbate 20 and poloxamer 188 in biopharmaceutical formulations using evaporative light scattering detection.
    Paschen CA; Klemm D; Graf T; Kopf R; Pinto C; Müller C; Bell CH; Pfaff J
    J Pharm Biomed Anal; 2021 Jan; 192():113640. PubMed ID: 33002754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acidic and alkaline hydrolysis of polysorbates under aqueous conditions: Towards understanding polysorbate degradation in biopharmaceutical formulations.
    Dwivedi M; Buske J; Haemmerling F; Blech M; Garidel P
    Eur J Pharm Sci; 2020 Mar; 144():105211. PubMed ID: 31931121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Existence of a superior polysorbate fraction in respect to protein stabilization and particle formation?
    Diederichs T; Mittag JJ; Humphrey J; Voss S; Carle S; Buske J; Garidel P
    Int J Pharm; 2023 Mar; 635():122660. PubMed ID: 36740078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaporative light scattering detection based HPLC method for the determination of polysorbate 80 in therapeutic protein formulations.
    Nayak VS; Tan Z; Ihnat PM; Russell RJ; Grace MJ
    J Chromatogr Sci; 2012 Jan; 50(1):21-5. PubMed ID: 22291052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitation of low concentrations of polysorbates in high protein concentration formulations by solid phase extraction and cobalt-thiocyanate derivatization.
    Kim J; Qiu J
    Anal Chim Acta; 2014 Jan; 806():144-51. PubMed ID: 24331050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation of polysorbate 20 in protein solutions using mixed-mode chromatography and evaporative light scattering detection.
    Hewitt D; Zhang T; Kao YH
    J Chromatogr A; 2008 Dec; 1215(1-2):156-60. PubMed ID: 19036378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the polysorbate degradation fingerprints and kinetics of lipases - how the activity of polysorbate degrading hydrolases is influenced by the assay and assay conditions.
    Glücklich N; Carle S; Buske J; Mäder K; Garidel P
    Eur J Pharm Sci; 2021 Nov; 166():105980. PubMed ID: 34419573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The degradation of polysorbates 20 and 80 and its potential impact on the stability of biotherapeutics.
    Kishore RS; Kiese S; Fischer S; Pappenberger A; Grauschopf U; Mahler HC
    Pharm Res; 2011 May; 28(5):1194-210. PubMed ID: 21369824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and stability study of polysorbate 20 in therapeutic monoclonal antibody formulation by multidimensional ultrahigh-performance liquid chromatography-charged aerosol detection-mass spectrometry.
    Li Y; Hewitt D; Lentz YK; Ji JA; Zhang TY; Zhang K
    Anal Chem; 2014 May; 86(10):5150-7. PubMed ID: 24749737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Free fatty acid particles in protein formulations, part 2: contribution of polysorbate raw material.
    Siska CC; Pierini CJ; Lau HR; Latypov RF; Fesinmeyer RM; Litowski JR
    J Pharm Sci; 2015 Feb; 104(2):447-56. PubMed ID: 25196966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On-line coupling of hydrophobic interaction column with reverse phase column -charged aerosol detector/mass spectrometer to characterize polysorbates in therapeutic protein formulations.
    He Y; Brown P; Bailey Piatchek MR; Carroll JA; Jones MT
    J Chromatogr A; 2019 Feb; 1586():72-81. PubMed ID: 30551943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poloxamer 188 as surfactant in biological formulations - An alternative for polysorbate 20/80?
    Bollenbach L; Buske J; Mäder K; Garidel P
    Int J Pharm; 2022 May; 620():121706. PubMed ID: 35367584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Characterization of Polysorbate.
    Zhang S; Xiao H; Li N
    Curr Protoc; 2022 Jul; 2(7):e489. PubMed ID: 35857882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Polysorbate Ester Fractions and Implications in Protein Drug Product Stability.
    Tomlinson A; Zarraga IE; Demeule B
    Mol Pharm; 2020 Jul; 17(7):2345-2353. PubMed ID: 32442382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative degradation of polysorbate surfactants studied by liquid chromatography-mass spectrometry.
    Borisov OV; Ji JA; Wang YJ
    J Pharm Sci; 2015 Mar; 104(3):1005-18. PubMed ID: 25581232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.